Daniel Holland-Moritz

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

2

H-Index

1

About

Daniel Holland-Moritz is a rising leader in the field of automated chemical synthesis and high-throughput reaction optimization. His research centers on developing integrated robotic platforms and real-time analytical tools to dramatically accelerate the discovery and optimization of chemical reactions. His most notable contribution is the invention of RAVE MS (Robotically Automated Vacuum Enabled Direct-Inject Mass Spectrometry), a low-cost, open-source system that couples an autosampler with a mass spectrometer to achieve a remarkable sampling rate of approximately 12 seconds per sample. This innovation enables continuous, real-time monitoring of reaction progress, offering comparable data quality to expensive commercial systems at a fraction of the cost. By democratizing access to high-speed analytics, Holland-Moritz’s work empowers labs worldwide to perform cross-modality reaction optimization with unprecedented speed and efficiency. His 2025 paper on RAVE MS has already garnered early citations, signaling its transformative potential. Through his pioneering efforts, Holland-Moritz is reshaping how chemists approach reaction development, making automation and rapid analysis accessible to a broader scientific community.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Accelerating cross-modality reaction optimization <i>via</i> robotically automated vacuum enabled direct-inject mass spectrometry (RAVE MS)
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago